Scientist, Diabetes Research Center - QBRI, and Assistant Professor, College of Science and Engineering, HBKU
NOV 14 - 15 2018
Share
6th annual 24 Hours of Stem Cells™ virtual event
There’s still time to check out the 6th annual 24 Hours of Stem Cells virtual event, the largest virtual stem cell event around the world.
During the on-demand period, you can:
- Access over 30 leading scientific presentations
- Expand your stem cell knowledge with training and tips from our stem cell experts
- Test your stem cell skills in virtual training labs
- Access hundreds of stem cell tools and resources such as handbooks, videos, protocols, app notes and more
- Enrich your perspective in a global context
Experience all of this from the comfort of anywhere. The virtual conference doors close on February 15, 2019.
Already registered? Login into the virtual environment
| What attendees liked about this year’s event | Explore the virtual event |
 |
|
If you have additional questions, please contact Chelsie Wajda at chelsie.wajda@thermofisher.com.
Speakers
-
Product Manager, Cell Biology Life Sciences Solutions Group Thermo Fisher Scientific -
Senior Global Cell Culture Specialist, Thermo Fisher Scientific
-
Stadtman Investigator, NIH, Unit on Ocular Stem Cell & Translational Research
-
Editor, Writer, and Statistical Consultant; Scientific Advisor, ScienceDocs
-
Scientist II, Thermo Fisher Scientific
-
Scientist II, Thermo Fisher Scientific
-
Weinert Center of Entrepreneurship at the Wisconsin School of Business, University of Wisconsin-Madison
-
Co-founder, ADCY5
-
Instructor in Neurology, Harvard Medical School
-
Associate Director - Stem & Primary Cell Group, AstraZeneca
-
Director and Group Leader, Thermo Fisher Scientific
-
Director, Human Resources at Thermo Fisher Scientific
-
Professor of Developmental Neurobiology Director of the Center for Regenerative Medicine, The Scripps Research Institute
-
R&D Scientist, Thermo Fisher Scientific
-
Principal Investigator, University of Cambridge
-
Senior Scientist, Cell and Gene Therapy Catapult
-
Professor, Department of Pediatrics/Cellular & Molecular Medicine, University of California, San Diego
-
Chief Technology Scientist, Centre for Brain development and Repair, Instem, Bangalore
-
Chief Technology Scientist, Centre for Brain development and Repair, Instem, Bangalore
-
Head of Research Professor of Biomedical Sciences, D'Or Institute for Research and Education (IDOR) & Institute of Biomedical Sciences Federal University of Rio de Janeiro
-
Senior Scientist, Roche
-
Assistant Professor, Department of Biomedical Engineering, Wisconsin Institute for Discovery, University of Wisconsin-Madison
-
Scientist, Research and Development, Cell Biology, Thermo Fisher Scientific
-
Assistant Professor, Department of Genetics and Genome Sciences, Case Western Reserve University
-
Postdoctoral Research Associate, Lead ID, The Scripps Research Institute
-
ARC DECRA Fellow, University of Melbourne
-
Associate Director, CuSTOM, Professor and Assistant Professor, Cincinnati Children's Hospital Tokyo Medical and Dental University Yokohama City University, Principal Investigator, Takeda-CiRA
-
CEO/Founder, RARE Science
-
Scientist I, Thermo Fisher Scientific
-
Staff Scientist, Thermo Fisher Scientific
You May Also Like
APR 29, 2020
6:00 AM PDT
Add to Calendar
Select one of the following:
iCal
Google Calendar
Outlook Calendar
Yahoo Calendar
iCal
Google Calendar
Outlook Calendar
Yahoo Calendar
APR 29, 2020
6:00 AM PDT
Add to Calendar
Select one of the following:
iCal
Google Calendar
Outlook Calendar
Yahoo Calendar
iCal
Google Calendar
Outlook Calendar
Yahoo Calendar
Luminex's xMAP® Technology enables the evaluation of up to 500 analytes simultaneously in a single well, known as multiplexing. xMAP Technology uses color-coded microspheres as the substrate...
NOV 14, 2019
6:00 AM PST
C.E. CREDITS
NOV 14, 2019
6:00 AM PST
Ten years ago LabRoots launched a new system of learning for a global scientific audience. Now, the 2019 Clinical Diagnostics and Research Virtual Event will again bring together clinicians,...
AUG 22, 2019
6:00 AM PDT
C.E. CREDITS
AUG 22, 2019
6:00 AM PDT
LabRoots is pleased to announce a new addition to our virtual conference line up for 2019, Forensics & Toxicology! The exciting field of Forensics/Toxicology is focused on a blend of biology...
SEP 26, 2019
6:00 AM PDT
C.E. CREDITS
SEP 26, 2019
6:00 AM PDT
LabRoots and the Cell Biology Planning Committee are please to announce the 3rd Annual Cell Biology Virtual Event, providing an opportunity to discuss recent discoveries in biological researc...
NOV 12, 2020
6:00 AM PST
Add to Calendar
Select one of the following:
iCal
Google Calendar
Outlook Calendar
Yahoo Calendar
iCal
Google Calendar
Outlook Calendar
Yahoo Calendar
NOV 12, 2020
6:00 AM PST
Add to Calendar
Select one of the following:
iCal
Google Calendar
Outlook Calendar
Yahoo Calendar
iCal
Google Calendar
Outlook Calendar
Yahoo Calendar
Ten years ago LabRoots launched a new system of learning for a global scientific audience. Now, the 2020 Clinical Diagnostics and Research Virtual Event will again bring together clinicians,...
SEP 11, 2019
6:00 AM PDT
C.E. CREDITS
SEP 11, 2019
6:00 AM PDT
LabRoots and the Microbiology Planning Committee is bringing the microbiology research community together at the 5th Annual Microbiology and Immunology Virtual Event! During the free, two-day...
Presentations
Share
-
NOV 15, 2018 1:00 PM PST
-
NOV 15, 2018 12:00 PM PST
-
NOV 15, 2018 11:00 AM PST
-
NOV 15, 2018 10:00 AM PST
-
NOV 15, 2018 9:00 AM PST
-
NOV 15, 2018 8:00 AM PST
-
NOV 15, 2018 7:00 AM PST
-
NOV 15, 2018 6:00 AM PST
-
NOV 15, 2018 4:00 AM PST
-
NOV 15, 2018 2:00 AM PST
-
NOV 14, 2018 3:00 PM PST
-
NOV 14, 2018 3:00 PM PST
-
NOV 15, 2018 2:00 AM PST
-
NOV 15, 2018 4:00 AM PST
-
NOV 15, 2018 6:00 AM PST
-
NOV 15, 2018 7:00 AM PST
-
NOV 15, 2018 8:00 AM PST
-
NOV 15, 2018 9:00 AM PST
-
NOV 15, 2018 10:00 AM PST
-
NOV 15, 2018 11:00 AM PST
-
NOV 15, 2018 12:00 PM PST
-
NOV 15, 2018 1:00 PM PST
Speakers
Share
-
Essam AbdelalimScientist, Diabetes Research Center - QBRI, and Assistant Professor, College of Science and Engineering, HBKUBiography
Dr. Essam M. Abdelalim is a scientist at QBRI and Assistant Professor at Hamad Bin Khalifa University (HBKU). He received his Ph.D. in Medical Science from Shiga University of Medical Science, Japan, and was later appointed as Assistant Professor in the same university. He was awarded a Postdoctoral Fellowship from the Japan Society for Promotion of Science (JSPS), where he identified novel genes involved in maintaining pluripotency and self-renewal of embryonic stem cells (ESCs). Since April 2014, Dr. Abdelalim has been leading the stem cell team focusing on diabetes at QBRI/HBKU. He has received several prestigious awards, including the State Prize of Encouragement (Egypt) in 2012 and the President's Award for outstanding PhD student from Shiga University of Medical Science (Japan) in 2007. Dr. Abdelalim is a member of the editorial board of "Stem Cells and Development" and "World Journal of Stem Cells". He is also a guest editor for "Stem Cell International" and "Frontiers in Cell and Developmental Biology". His current research at QBRI focuses on using pluripotent stem cell technology to investigate the pathophysiology underlying the development of diabetes and insulin resistance as well as generating stem cell-derived pancreatic beta cells for cellular therapy. He is currently leading several diabetes-related projects funded by QBRI and QNRF. Recently, he has been awarded two NPRP grants (NPRP9 and NPRP10) and two QBRI Internal Research grants to study diabetes and pancreatic beta cell differentiation. -
Joanna AsprerProduct Manager, Cell Biology Life Sciences Solutions Group Thermo Fisher ScientificBiography
Joanna Asprer has over ten years of experience as a bench scientist and six years of experience in the bioscience industry. She received her doctorate in Developmental Biology from Baylor College of Medicine in Houston, Texas, where her dissertation was on the transcriptional regulation of neuronal differentiation in the cerebral cortex and spinal cord. After a postdoctoral position studying inner ear development at Baylor College of Medicine, she obtained business training at Keck Graduate Institute. Joanna then joined Life Technologies (now a part of Thermo Fisher Scientific) as a scientist in Research and Development. There, she developed tools for the pluripotent stem cell workflow and supported product management in the commercialization of these products. For the last three years, Joanna has been a product manager with the same company, where she works with a cross-functional core team to develop, commercialize, support, and grow products in the pluripotent stem cell workflow, most prominently, PSC culture media for basic research or for cell therapies. -
Mary Kay BatesSenior Global Cell Culture Specialist, Thermo Fisher ScientificBiography
Mary Kay Bates is a Senior Global Cell Culture Specialist with Thermo Fisher Scientific, where she provides cell culture expertise to colleagues and customers. Her knowledge is based on twenty years of experience in academic and industrial cell and molecular biology labs, focusing on cancer and gene therapy, authoring several publications. Mary Kay holds an M.S. in microbiology from the University of Wisconsin-Madison, and has presented seminars at institutes around the world. -
Kapil BhartiStadtman Investigator, NIH, Unit on Ocular Stem Cell & Translational ResearchBiography
Dr. Kapil Bharti holds a bachelor's degree in Biophysics from the Panjab University, Chandigarh, India, a master's degree in biotechnology from the M.S. Rao University, Baroda, India, and a diploma in molecular cell biology from Johann Wolfgang Goethe University, Frankfurt, Germany. He obtained his Ph.D. from the same institution, graduating summa cum laude. His Ph.D. work involved research in the areas of heat stress, chaperones, and epigenetics. He did his postdoc at the National Institutes of Health, where he published numerous papers in the areas of transcription regulation, pigment cell biology, and developmental biology of the eye. He has won several awards, including, most recently, being selected as an Earl Stadtman Tenure-Track Investigator at NIH. His lab was recently awarded two prestigious grants: 1) the only Intramural Common Fund grant to develop a phase I Investigational New Drug (IND) for Autologous induced pluripotent stem cell derived retinal pigment epithelium tissue; and 2) a DoD grant to develop a 3D-retina tissue to model retinal diseases in vitro. His current work as the head of the Unit on Ocular and Stem Cell Translational Research involves understanding mechanism of retinal degenerative diseases using induced pluripotent stem cell technology, and developing cell-based and drug-based therapies for such diseases. -
Devon Brewer, Ph.D.Editor, Writer, and Statistical Consultant; Scientific Advisor, ScienceDocsBiography
Devon Brewer has 25 years of experience in writing successful grant proposals in the health sciences. He has been principal investigator on several grants and a key contributor to many others. Brewer has written funded proposals or reviewed proposals for NIH, NSF, CDC, HRSA, MRC (UK), private foundations, and other agencies. As a scientific advisor and writer with ScienceDocs, he helps researchers develop and compose effective proposals and manuscripts. -
Carl DargitzScientist II, Thermo Fisher ScientificBiography
Carl Dargitz received his Master's degree from California Polytechnic State University, San Luis Obispo in Biomedical Engineering with a specialization in stem cell research in 2013. During that time he worked as an intern at The Salk Institute in Dr. Inder Verma's lab under the tutelage of Dr. Amy Firth. His Master's thesis project involved differentiating iPSCs into lung airway epithelium to study Cystic Fibrosis. From 2013-2016 he worked at the stem cell core facility at The Salk Institute managing the core's reprogramming services. In August 2016 he joined the stem cell R&D team at Thermo Fisher Scientific as a Scientist II developing reprogramming, PSC characterization, and immunoncology characterization products. -
Jordan DizonScientist II, Thermo Fisher ScientificBiography
Jordan A. Dizon did her undergraduate degree BSc (Cellular and Molecular Biology) at San Diego State University (San Diego, California). She then became a California Institute for Regenerative Medicine (CIRM) Bridges Intern in the lab of Lawrence SB. Goldstein at the University of California, San Diego (San Diego, California) where she performed her research to complete her MSc (Biology). Here her research involved the use of CRISPR/Cas9-mediated genome editing in hiPSCs to model relevant neurodegenerative disease cellular phenotypes. After her degree, she came to work for Thermo Fisher Scientific as a Scientist in the Custom Driven Biology Services Team in Carlsbad, California. Jordan is involved heavily in a lot of the iPSC related projects, including genome editing ad reprogramming, as well as projects involved in the use of our neuronal product portfolio, including NSC induction, neuronal maturation and high-throughput neuronal assays. -
Phil GreenwoodWeinert Center of Entrepreneurship at the Wisconsin School of Business, University of Wisconsin-MadisonBiography
As an educator and trainer in the fields of accounting, finance, and entrepreneurship, Phil has designed and instructed numerous courses for MBA, Executive MBA and executive education customers. Currently, he is a Senior Lecturer for the Weinert Center of Entrepreneurship at the Wisconsin School of Business, University of Wisconsin-Madison (consistently ranked among the top 25 entrepreneurship programs by Financial Times and Entrepreneur magazine). Over the past decade, Phil has taught courses in Entrepreneurial Finance, New Venture Creation, Entrepreneurial Management, and Strategic Management at the undergraduate and full-time MBA levels. Phil is also an adjunct faculty member with the Executive MBA - Kohl's Program, the Evening MBA Program, and Executive Education. Topics include Corporate Finance, Financial Management, Business Valuation, and Financial Analysis. Finally, Dr. Greenwood is a founding faculty member with the Morgridge Entrepreneurial Bootcamp (MEB) and Master's in Biotechnology program sponsored by the UW-Medical School. Phil has extensive experience instructing at other institutions including the Copenhagen Business School MBA, Copenhagen, Denmark; University of St. Thomas in the Twin Cities, Minnesota; MBA program at HEC University in Versailles, France; Executive MBA program at KÖC University based in Istanbul, Turkey; and, the Executive MBA program at the Chinese Academy of Sciences in Beijing, China. -
Gay GrossmanCo-founder, ADCY5Biography
Gay started ADCY5.org to provide a place for newly diagnosed families of ADCY5 related-Dyskinesia, an ultra Rare Disease. They currently have one of the largest Rare Disease stem cell projects. Working with biotech partners, almost $3 million has been dedicated to ADCY5 related-Dyskinesia related science through ADCY5.org. Speaking publicly at conferences and to organizations about the first hand experience of Whole Genome Sequencing, personalizes how a diagnosis for her daughter, after 15 years, changed their family's lives. Sharing this story with a variety of audiences including, but not limited to, precision medicine conferences, patient advocacy conferences, and graduate and medical school seminars, fosters partnerships within our community. We Are All Rare, a patient education book Gay co-authored, together with her daughter, who has a Rare Disease, provides an educational tool for families entering primary school, complete with a list of valuable resources. Meeting with her Congressman to encourage support of The OPEN ACT, Medicaid reimbursement, and access for persons with disabilities, gives her the opportunity to share the patient family perspective with policy makers. She is currently serving on the Global Genes Foundation Alliance Advisory Council, their Summit Planning Committee for the 2018 International RARE Patient Advocacy Summit, and on the developing team for the Genetics 101 class. She is an Ambassador for Illumina; for the Rare Undiagnosed Genetic Disease (RUGD) program. Gay works with key opinion leaders like Rare Science, Global Genes, EveryLife Foundation, and other patient advocacy organizations to engage through social media, conferences, and personal networking. Gay started her career in Sales and Sales Training with Glaxo Inc. where she directed a study on Physician Impressions of Corticosteroids and how to best position them in the marketplace. Gay uses this foundation of science and her own experience to relate the burden of disease, bringing awareness through advocacy and public speaking. She successful advocates in environments including, but not limited to, educational classrooms, private, state, and federal insurance, and collaborating in the Rare Disease space to gain access to medical therapies. -
William HendriksInstructor in Neurology, Harvard Medical SchoolBiography
After receiving his PhD in Neuroscience at the VU University Amsterdam in the Netherlands in 2008, Dr. Hendriks joined the lab of Dr. Paola Arlotta at the Center for Regenerative Medicine of Massachusetts General Hospital (MGH) in Boston to study neuronal development focusing on neuronal differentiation of human pluripotent stem cells. In 2011, Dr. Hendriks joined the Harvard Stem Cell Institute (HSCI) iPS Core facility with Dr. Chad Cowan at Harvard University in Cambridge, where initially he worked on developing and implementing foot-print free somatic cell iPSC reprogramming methods. Dr. Hendriks also initiated and managed the hPSC genome editing service for 2 years at HSCI before moving to his current position as a Harvard Medical School Instructor in Neurology at the MGH Collaborative Center for X-Linked Dystonia Parkinsonism in 2014. -
Ryan HicksAssociate Director - Stem & Primary Cell Group, AstraZenecaBiography
Ryan Hicks is the Associate Director of the Stem & Primary Cell Group at AstraZeneca. Ryan's group is responsible for the generation, engineering and differentiation of iPS cells, adult stem cells and use of primary cells for assay development, target validation, hit finding, hit-to-lead, lead optimization and phenotypic screening activities. Models are generated in 2D and 3D cultures and part of the model development work includes using precise genome modification techniques to introduce gene knock-outs, knock-in mutations or endogenous reporters into iPS cells. The groups work primarily focuses on AstraZeneca's cardiovascular, metabolic, renal and respiratory disease areas. Ryan Hicks joined AstraZeneca in 2001 and has been based in Sweden for the past 8 years. Prior to working in Sweden, Ryan worked as the Associate Director of the Cell & Protein reagents group at AstraZeneca, Alderley Park, UK, with responsibilities in the cell and protein disciplines. Ryan Hicks received his degree in Medical Biochemistry from the University of Birmingham, UK. Following this Ryan received his Ph.D. in Biochemistry and Molecular Biology from the University of Leeds, UK, in 2001. -
David Kuninger, PhDDirector and Group Leader, Thermo Fisher ScientificBiography
Dr. Kuninger leads research, development and commercialization of media systems for pluripotent stem cell culture & differentiation, neurobiology, and (non-hepatic) primary cell biology at Thermo Fisher Scientific in the Cell Biology business based in Frederick MD. His teams support numerous portfolios and have launched over 25 new products spanning stem cell culture & cryopreservation, differentiation (endo-, ecto- and meso-dermal lineages) and neurobiology over the past 3 years. David is a seasoned scientist and manager, experienced in media formulation & optimization, assay design and implementation, and troubleshooting. Expertise in GLP/GMP compliance, tech transfer and scale up, as well as verification and validation processes. Prior to starting at Thermo Fisher Scientific (legacy Invitrogen) in 2007 as Staff Scientist, he joined Oregon Health Sciences University as a Postdoctoral Fellow investigating the actions of insulin-like growth factors in the lab of Dr. Peter Rotwein, subsequently joining the faculty in the Department of Biochemistry at OHSU as a Research Instructor. He completed is PhD in Biochemistry and Genetics University of Texas Medical Branch in the laboratory of Dr. John Papaconstatinou and has a B.S. in Chemistry from the University of Oregon. -
Joseph LaPointeDirector, Human Resources at Thermo Fisher ScientificBiography
Joseph LaPointe is a Human Resources leader at Thermo Fisher Scientific with over 30 years of experience in Fortune 250 organizations. He has held a variety of roles and is known for his career coaching and leadership development ability -
Jeanne LoringProfessor of Developmental Neurobiology Director of the Center for Regenerative Medicine, The Scripps Research InstituteBiography
Jeanne F. Loring is a Professor and the founding Director of the Center for Regenerative Medicine at The Scripps Research Institute in La Jolla. Her laboratory studies human pluripotent stem cells (hPSCs), the remarkable cells that can make every cell type in the body. Her lab is developing a patient-specific cell replacement therapy for Parkinson's disease and a stem cell-based treatment for multiple sclerosis, and they are studying the underlying causes of autism. With the San Diego Zoo, her lab is developing a "zoo" of induced pluripotent stem cells from endangered species to aid in their conservation. Dr. Loring serves on many scientific and bioethics advisory boards and is frequently quoted in major newspapers, appears on television and in documentary features, and gives many public lectures about science and society. She is particularly concerned with the dangers of unregulated stem cell treatments in the US and other countries ("stem cell tourism"). In 2015, she was designated "Stem Cell Person of the Year" by The Niche blog, and was awarded the Stem Cell Action Advocacy Award by the World Stem Cell Summit. -
Chad MacArthurR&D Scientist, Thermo Fisher ScientificBiography
Chad MacArthur is a R&D Scientist in Cell Biology at Thermo Fisher Scientific. During his 10+ years in R&D, Chad has worked on many different aspects of the PSC workflow including cell engineering, media development, and reprogramming technologies. -
Florian MerklePrincipal Investigator, University of CambridgeBiography
Florian T. Merkle received his B.S. in biology from the California Institute of Technology (Caltech), which he attended on full tuition merit scholarship. Florian pursued his Ph.D. neuroscience at the University of California, San Francisco (UCSF), where he studied adult neurogenesis in the laboratory of Prof. Arturo Alvarez-Buylla. His work revealed the embryonic origin of adult neural stem cells, overturned the widely-held belief that these stem cells are homogeneous and multipotent, and discovered several new types of adult-born cell types. As a postdoctoral fellow at Harvard University, Florian worked with Prof. Alex Schier and Prof. Kevin Eggan to develop gene editing tools in human pluripotent stem cells (hPSCs) and to sequence and bank a large collection of hPSCs to facilitate disease modelling and transplantation studies. He developed novel methods to differentiate hPSCs into hypothalamic neurons that regulate essential physiological processes and are therefore pivotally important for human health, and whose abnormal function causes a range of diseases including obesity. Florian now leads a research group at the University of Cambridge where he is studying obesity using in vitro disease models and pursuing questions relating to the genetic stability of hPSCs. These studies are supported by the Wellcome Trust, Royal Society, and Academy of Medical Sciences. -
Rhys MacownSenior Scientist, Cell and Gene Therapy CatapultBiography
Rhys Macown, Ph.D, is a senior scientist in the process industrialisation team at Cell and Gene Therapy Catapult UK. Rhys earnt a BE(Hons) in chemical and process engineering at University of Canterbury (NZ) before starting his career with a PhD in biochemical engineering in Prof. Nicolas Szita's group at University College London. There he designed and tested a microfluidic system for the 2D adherent culture of pluripotent stem cells with fine control over the micro-environment. Since joining the Cell and Gene Therapy Catapult in 2014, Rhys has been continually active on fee-for-service, collaborative, and core-funded projects developing pluripotent stem cell based processes and has played a leading role exploring the 3D expansion of pluripotent stem cells as aggregates. -
Alysson MuotriProfessor, Department of Pediatrics/Cellular & Molecular Medicine, University of California, San DiegoBiography
Dr. Muotri earned a BSc in Biological Sciences from the State University of Campinas in 1995 and a Ph.D. in Genetics in 2001 from University of Sao Paulo, in Brazil. He moved to the Salk Institute as Pew Latin America Fellow in 2002 for a postdoctoral training in the fields of neuroscience and stem cell biology. He has been a Professor at the School of Medicine, University of California in San Diego since late 2008. His research focuses on modeling neurological diseases, such as Autism Spectrum Disorders, using human induced pluripotent stem cells. His lab has developed several techniques to culture human neurons and glia for basic research and drug-screening platforms. He has received several awards, including the prestigious NIH Director's New Innovator Award, NARSAD, Emerald Foundation Young Investigator Award, Surugadai Award from Tokyo University, Rock Star of Innovation from CONNECT, NIH EUREKA Award among others. -
Rakhi PalChief Technology Scientist, Centre for Brain development and Repair, Instem, BangaloreBiography
Dr. Rakhi Pal is the Chief technology scientist at the Centre for Brain Development and Repair, Institute of Stem cell biology and Regenerative medicine, Bangalore,India where she works on using stem cell based technologies to develop platforms for understanding neuro-developmental disorders. A Gold medalist in Human Physiology from the prestigious All India Institute of Medical Sciences, New Delhi and a PhD from Manipal University, Dr Pal has more than 10 years of experience in the field of stem cell biology with particular interest in neurological disorders. She not only has multiple publications and patents to her name, but also possesses an unique blend of both industry and academic experiences. -
Daniel PaullChief Technology Scientist, Centre for Brain development and Repair, Instem, BangaloreBiography
Dr. Paull is Vice President, Automation Systems and Stem Cell Biology at The NYSCF Research Institute. Daniel oversees the day-to-day operation of The NYSCF Global Stem Cell Array in both the production of induced pluripotent stem cells and development of novel tools using the robotic platform including such areas as gene editing and differentiation. He also oversees a number of collaborative projects aimed at developing research across a range of disease areas. He received his PhD from University College London, England and followed this with post-doctoral work at the New York Stem Cell Foundation where he helped develop novel approaches for the treatment of mitochondrial disease as well as furthered research into somatic cell nuclear transfer. -
Stevens RehenHead of Research Professor of Biomedical Sciences, D'Or Institute for Research and Education (IDOR) & Institute of Biomedical Sciences Federal University of Rio de JaneiroBiography
Stevens Rehen received his Bachelor's degree, Master's degree, and Ph.D. at the Federal University of Rio de Janerio in Brazil. He later completed postdoctoral training at the University of California San Diego and The Scripps Research Institute. Over the past five years, Stevens has published over 76 peer-reviewed publications. Currently, Stevens is a Full Professor at the Federal University of Rio de Janerio. Additionally, he is the Head of Research at D'Or Institute for Research and Education (IDOR) and Regional Committee Member of the Pew Latin American Program in the Biomedical Sciences -
Filip RoudnickySenior Scientist, RocheBiography
Filip Roudnicky is a senior scientist in the disease relevant cellular assay team in chemical biology at Roche. His is responsible for genome editing for disease modeling and for CRISPR/Cas9 genetic screens. He is also expert on disease relevant cellular assays involving endothelial cells. Filip started his career with a PhD in a lab of Prof. M. Detmar at ETH Zurich. He studied tumor angiogenesis of invasive bladder carcinoma and identified several biomarkers and molecular targets on tumor-associated blood vessels of bladder cancer. As a guest research scientist he has worked, in RIKEN Yokohama, Japan, under Dr. Jay W. Shin, on induced-neuronal stem cells and RNA-sequencing analysis. He has been a postdoctoral fellow in Roche and Harvard with the lab of Prof. C. Cowan developing an in vitro model of retinal endothelial cells. -
Kris SahaAssistant Professor, Department of Biomedical Engineering, Wisconsin Institute for Discovery, University of Wisconsin-MadisonBiography
Krishanu Saha is an Assistant Professor in the Department of Biomedical Engineering at the University of Wisconsin-Madison. He is also a member of the Wisconsin Institute for Discovery, Carbone Cancer Center, and Stem Cell and Regenerative Medicine Center as well as the National Academies' Forum on Regenerative Medicine. Prior to his arrival in Madison, Dr. Saha studied Chemical Engineering at Cornell University and at the University of California in Berkeley. He was a Society in Science: Branco-Weiss fellow at the Whitehead Institute for Biomedical Research at MIT and in the Science and Technology Studies program at Harvard University. Major thrusts of his lab involve gene editing and cell engineering of human cells found in the retina, central nervous system and blood. -
Lauren SangenarioScientist, Research and Development, Cell Biology, Thermo Fisher ScientificBiography
Lauren completed her BS in Biology at Virginia Tech and MS in Biotechnology at Johns Hopkins University before joining Life Technologies (now part of Thermo Fisher Scientific) in 2013 as an R&D Scientist. Her development work focuses on next generation stem cell culture systems, providing researchers efficient tools for stem cell culture, cryopreservation and differentiation. Her recent work has focused on development of cell therapy grade products enabling stem cell culture for translational and clinical research. -
Ashleigh SchafferAssistant Professor, Department of Genetics and Genome Sciences, Case Western Reserve UniversityBiography
Ashleigh Schaffer graduated with a B.S. in Genetics from University of Wisconsin-Madison and went on to earn her Ph.D. from the University of California, Irvine under the mentorship of Dr. Maike Sander. She continued her training as a postdoctoral fellow at the University of California, San Diego, and Howard Hughes Medical Institute under the guidance of Dr. Joseph G. Gleeson, focused on elucidating the genetic cause, and molecular mechanisms, underlying recessive pediatric neurological disease. During her time with Dr. Gleeson, Ashleigh discovered over 20 novel genetic causes of disease, many for recessive, syndromic pediatric neurodegenerative disorders. She joined the Department of Genetics and Genomes Sciences at Case Western Reserve University as an Assistant Professor in February 2017. -
BanuPriya SridharanPostdoctoral Research Associate, Lead ID, The Scripps Research InstituteBiography
Banu Priya Sridharan, PhD, is a Postdoctoral Research Associate at the Scripps Research Institute Molecular Screening Center in the department of Molecular Medicine at Scripps in Florida. After a brief stint in MIT-Harvard HST as an undergraduate research assistant, she trained as a tissue engineer in Lawrence, Kansas where she obtained her Ph.D. in 2015. She moved to Medimmune to do a short-term industrial fellowship. She began at Scripps Florida in 2016 to advance her expertise on developing stem-cell based tissue models but now in the context of HTS. Dr. Sridharan pursued her passion for employing cellular models for phenotypic screening and is deeply involved in iPSC-based neuronal differentiation protocols, genome editing for disease modeling and relevant drug screening. Since 2011, she has published numerous peer reviewed articles and conference posters and podium talks and her key expertise includes stem cell differentiation, phenotypic assay development, high throughput screening and high content analysis. -
Lincon StampARC DECRA Fellow, University of MelbourneBiography
Dr. Lincon Stamp did his undergrad degree, BSc (Biotechnology) at the University of Newcastle (Australia). Here he developed a strong interest in stem cell biology and so moved to Melbourne to do Honours and then PhD with Prof Martin Pera at Monash University. Here his research involved investigation of the early differentiation of human embryonic stem cells toward hepatopancreatic cell fates. He then joined the lab of Dr. Don Newgreen at the Murdoch Children's Research Institute where he began working on development of the enteric nervous system, before joining Prof Heather Young's lab at the University of Melbourne Department of Anatomy and Neuroscience, where he has been focused on developing a stem cell therapy to treat gut motility disorders such as the pediatric enteric neuropathy Hirschprung disease. Lincon is an ARC DECRA Fellow and holds an NHMRC Project Grant as CIB with Prof Young, and has recently published a number of high impact studies in the Gastroenterology, Journal of Clinical Investigation and Stem Cell Reports. -
Takanori TakebeAssociate Director, CuSTOM, Professor and Assistant Professor, Cincinnati Children's Hospital Tokyo Medical and Dental University Yokohama City University, Principal Investigator, Takeda-CiRABiography
Dr. Takebe is an Associate Director of Center for Stem Cell and Organoid Medicine (CuSTOM) at the Cincinnati Children's Hospital Medical Center and Professor at Yokohama City University, and Tokyo Medical and Dental University, Japan. He serves as Board of Directors at International Society of Stem Cell Research (ISSCR). His lab investigates the mechanisms of human organogenesis, and develops mini-organ technologies from human stem cells - namely organ bud based approaches. He is applying iPSC-liver buds into drug discovery study as well as transplant application - for patients with a rare congenital metabolic disorder, ultimately expanding the clinical indications to diseases like liver cirrhosis. -
Christina WatersCEO/Founder, RARE ScienceBiography
Dr. Christina Waters' broad range of experience in leading medical research in both biotech/large pharmaceutical companies to non-profits converge to specialize in new approaches to personalized medicine and implementation of new innovative research initiatives to accelerate treatments to patients. She serves as SVP and GM of the Global Rare Disease Program at WuXi NextCODE and Founder/CEO of RARE Science, a non-profit research organization that accelerates discovery of therapeutic solutions for kids with rare disease. She serves as a Scientific Advisory board member, for Global Genes, which focuses on rare disease advocacy. Dr. Waters received her Ph.D. in Genetics from UC Davis and was a Postdoctoral Scholar and Associate of the Howard Hughes Medical Institute, California Institute of Technology. Dr. Waters completed an NIH Postdoctoral fellowship at University of California, Berkeley, and received a BS degree from San Diego State University. Dr. Waters received her MBA from UCLA. -
Jackie WebbScientist I, Thermo Fisher ScientificBiography
Jackie completed her undergraduate degree BSc (Biochemistry) at UCLA. After her degree, she spent a year at a biotech/computer science startup in South San Francisco, California and then joined Thermo Fisher Scientific as a Scientist on the Custom Driven Biology Services Team in Carlsbad, California, where she is responsible for many projects involving the hiPSC and neuronal product portfolios. -
Erik Willems, PhDStaff Scientist, Thermo Fisher ScientificBiography
Dr. Erik Willems was trained as a stem cell biologist in Brussels, Belgium where he obtained his PhD in 2007, after which he soon relocated to San Diego, California to develop his expertise in the use of pluripotent stem cells in high throughput screening assays for understanding the basic biology and disease of the developing heart at the Sanford Burnham Prebys Medical Discovery Institute. Dr. Willems then pursued his passion for the development of biotechnology tools and applications and joined Thermo Fisher Scientific in Carlsbad, California where he - as a Manager in the Cell Biology group - currently leads a team focused on pluripotent stem cell-based customer driven projects and product applications, including characterization, reprogramming, genome editing, differentiation and disease modeling with a focus on drug discovery applications. Now in the stem cell field for over 15 years, Dr. Willems published numerous peer reviewed articles including in high impact journals such as Cell Stem Cell. His key expertise includes pluripotent stem cell biology, differentiation, genome editing, high throughput screening and drug discovery.
Education
Share
What educational opportunities are available on-demand?
Training
Watch behind-the-scenes training with our stem cell experts.
Scientific presentations
Hear from over 30 prominent researchers and thought leaders in the industry worldwide.
Education Center
Visit the Education Center to access the latest educational tools including virtual training labs and stem cell quizzes.
Resources
Access and download hundreds of stem cell tools and resources including handbooks, protocols, app notes, videos and more.
Help
General LabRoots Questions
For bugs, spam, technical support or questions please call +1-714-463-4673 or
email support@labroots.com
Virtual Events and Webinars
Supported Configurations
-
Operating System Internet Explorer Firefox Chrome Safari Vista IE8+ FF10+ Chrome15+ Windows 7 IE8+ FF10+ Chrome15+ Windows 8 IE10 FF10+ Chrome15+ Mac OS X FF10+ Chrome15+ Safari5.1+
- Cookie settings: session cookies enabled
- Browser configuration must have JavaScript enabled
- Adobe Flash player 10.2 or later
To watch our webinars and virtual events a modern browser such as Chrome, Firefox, Safari, or an updated version of Internet Explorer is required.
Internet Connection
- A minimum of 100Kbps is recommended for audio-only events
- A minimum of 300Kbps is recommended for speaker on-video events
Computer Equipment
- Screen Resolution: Minimum 1024x768
- Video Card: 65,000 colors minimum
- Sound card and speakers (or headphones) for hearing webcast in full format
- Audio Card: 16-bit minimum
- RAM: 512MB of free RAM
Firewall Protocol
- HTTP on port 80 or HTTPS on port 443
- Adobe RTMP on port 1935, 80, or 443 with automatic fall-back to RTMPT (RTMP tunneling) on ports 1935, 80 or 443
- RTMPE (RTMP encrypted) on ports 1935, 80 or 443
Work-At-Home Attendees
- If a corporate VPN is used, confirm that your network traffic is not directed over the company VPN. If it is, please turn off the VPN while attending the virtual event.
For A Seamless Experience
- Registration is required for most events
- Adobe Flash Player is needed to view webinar videos
- Self Test your system compatibility ahead of time
When using a mobile device, FREE Mobile Apps are available:
- For viewing Webinars:
- iPhone/iPad, download the Webcast Studio App
- Android device, download the Webcast Studio App
- For viewing Virtual Events
- iPhone/iPad, download the Virtual Environments App
- Android, download the Virtual Environments App
Attendee Guide
- To learn more about how the virtual event works for attendees, download the Attendee Guide (PDF).
Virtual Event and Webinar Support:
- Phone: +1-714-463-4673
- Email: support@labroots.com
- Webpage: About Virtual Events
Continuing Education (CME/CE) Support
- Phone: +1-714-930-3518
- Email: CE@labroots.com
- Webpage: Continuing Education CME/CE Credits
Loading Comments...
-
JAN 29, 2020 9:00 AM PST
-
JAN 29, 2020 9:30 PM PST
-
JAN 30, 2020 8:00 AM PST
-
JAN 30, 2020 9:00 AM PST
-
FEB 05, 2020 8:00 AM PST
-
JAN 24, 2020
-
JAN 24, 2020
